共 50 条
- [31] Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 Hepatology International, 2022, 16 : 1001 - 1019
- [32] Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study ANNALS OF GASTROENTEROLOGY, 2020, 33 (03): : 285 - 292
- [34] Efficacy and Safety Profile of Direct-Acting Antiviral Agents in Hemodialysis Patients With Chronic Hepatitis C Infection AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S557 - S558
- [36] Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals Drugs & Aging, 2018, 35 : 117 - 122
- [37] Electrophysiological Adverse Effects of Direct-Acting Antivirals in Patients With Chronic Hepatitis C JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07): : 931 - 932
- [40] Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals HEPATOLOGY FORUM, 2020, 1 (02): : 53 - 58